An Open-Label Pilot Study of Adrenocorticotrophic Hormone in the Treatment of IgA Nephropathy at High Risk of Progression

INTRODUCTION: IgA nephropathy (IgAN) is the most common glomerulonephritis with high risk of progression to end-stage renal disease in patients with proteinuria >1 g/24 hours. There are no known effective treatments in patients with IgAN. METHODS: We conducted a prospective open-label pilot study...

Descripción completa

Detalles Bibliográficos
Autores principales: Zand, Ladan, Canetta, Pietro, Lafayette, Richard, Aslam, Nabeel, Jan, Novak, Sethi, Sanjeev, Fervenza, Fernando C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943772/
https://www.ncbi.nlm.nih.gov/pubmed/31922061
http://dx.doi.org/10.1016/j.ekir.2019.10.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943772/
https://www.ncbi.nlm.nih.gov/pubmed/31922061
http://dx.doi.org/10.1016/j.ekir.2019.10.007

Ejemplares similares